pre-seed
Stage
1
Investors
About
Aurigen Medical develops the Zenith left atrial appendage occlusion (LAAO) device for treating patients with atrial fibrillation to reduce stroke risk. The company has successfully completed first-in-human implantation procedures as part of clinical validation.
Explore Aurigen Medical's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.